These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4725358)

  • 21. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):270-6. PubMed ID: 5054735
    [No Abstract]   [Full Text] [Related]  

  • 22. Injections of deuterated tryptamine into the nucleus accumbens of the rat: effects on locomotor activity and monoamine metabolism.
    Marien MR; Gerber R; Boyar WC; Altar CA
    Neuropharmacology; 1987 Oct; 26(10):1481-8. PubMed ID: 3683763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modification of the metabolism of cerebral serotonin (5-HT) induced in rats by the administration of 6-hydroxydopamine].
    Blondaux C; Juge A; Sordet F; Chouvet G; Jouvet M; Pujol JF
    Brain Res; 1973 Feb; 50(1):101-14. PubMed ID: 4690541
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of ethanol on the oxidative metabolism of tryptamine by rat liver homogenate.
    Asaad MM; Barry H; Clarke DE; Dixit BN
    Br J Pharmacol; 1974 Feb; 50(2):277-82. PubMed ID: 4371901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of binding of aldehydes of biogenic amines in tissues.
    Ungar F; Tabakoff B; Alivisatos SG
    Biochem Pharmacol; 1973 Aug; 22(15):1905-13. PubMed ID: 4722459
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitroglycerin (glyceryl trinitrate) as a monoamine oxidase inhibitor.
    Ogawa K; Gudbjarnason S; Bing RJ
    J Pharmacol Exp Ther; 1967 Mar; 155(3):449-55. PubMed ID: 4960617
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro pigment formation from tryptamine. Role of indole-3-acetaldehyde.
    Das PK; Guha SR
    Biochem Pharmacol; 1985 Aug; 34(15):2663-7. PubMed ID: 4015706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro.
    Saavedra JM; Axelrod J
    Science; 1972 Mar; 175(4028):1365-6. PubMed ID: 5059565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of monoamine oxidase inhibitors on metabolism and in vivo release of H 3 -norepinephrine from the hypothalamus.
    Strada SJ; Sulser F
    Eur J Pharmacol; 1972 May; 18(3):303-8. PubMed ID: 4556296
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical implications of monoamine oxidase inhibition.
    Pare CM
    Adv Biochem Psychopharmacol; 1972; 5():441-4. PubMed ID: 5054212
    [No Abstract]   [Full Text] [Related]  

  • 34. The subcellular distribution of endogenous and exogenous serotonin in brain tissue: comparison of synaptosomes storing serotonin, norepinephrine, and gamma-aminobutyric acid.
    Kuhar MJ; Shaskan EG; Snyder SH
    J Neurochem; 1971 Mar; 18(3):333-43. PubMed ID: 5559247
    [No Abstract]   [Full Text] [Related]  

  • 35. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of monoamine oxidase inhibitors on the tryptamine content of the rat brain and on "tryptamine convulsions"].
    Popov N; Lietz W; Matthies H
    Acta Biol Med Ger; 1967; 18(2):233-44. PubMed ID: 5586804
    [No Abstract]   [Full Text] [Related]  

  • 38. On the condensation of tryptamine & indole-3-acetaldehyde.
    Das PK; Dutta PK; Guha SR
    Indian J Biochem Biophys; 1983 Dec; 20(6):390-1. PubMed ID: 6674123
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of tranylcypromine and pargyline on brain tryptamine.
    Tabakoff B; Moses F; Philips SR; Boulton AA
    Experientia; 1977 Mar; 33(3):380-1. PubMed ID: 870336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
    Yu PH; Davis BA; Durden DA; Barber A; Terleckyj I; Nicklas WG; Boulton AA
    J Neurochem; 1994 Feb; 62(2):697-704. PubMed ID: 8294932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.